BR0103434A - Composições para fins terapêuticos compreendendo excesso enantiomérico - Google Patents

Composições para fins terapêuticos compreendendo excesso enantiomérico

Info

Publication number
BR0103434A
BR0103434A BR0103434-0A BR0103434A BR0103434A BR 0103434 A BR0103434 A BR 0103434A BR 0103434 A BR0103434 A BR 0103434A BR 0103434 A BR0103434 A BR 0103434A
Authority
BR
Brazil
Prior art keywords
compositions
enantiomeric excess
therapeutic purposes
hypertensive
concerned
Prior art date
Application number
BR0103434-0A
Other languages
English (en)
Inventor
Suresh Babubhai Chahwala
Michael George Dodd
Michael John Humphrey
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9898193&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0103434(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of BR0103434A publication Critical patent/BR0103434A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: "COMPOSIçõES PARA FINS TERAPEUTICOS COMPREENDENDO EXCESSO ENANTIOMéRICO". A presente invenção refere-se a composições farmacêuticas compreendendo uma mistura de enantiómeros de anlodipina, sendo que estas composições apresentam tanto propriedades cardiovasculares anti-hipertensivas como propriedades adicionais, que derivam respectivamente da sua atividade como bloqueadores de canal de cálcio e da sua capacidade para liberar óxido nítrico (NO) vascular.
BR0103434-0A 2000-08-23 2001-08-17 Composições para fins terapêuticos compreendendo excesso enantiomérico BR0103434A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0020842.1A GB0020842D0 (en) 2000-08-23 2000-08-23 Therapeutic compositions

Publications (1)

Publication Number Publication Date
BR0103434A true BR0103434A (pt) 2002-03-26

Family

ID=9898193

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0103434-0A BR0103434A (pt) 2000-08-23 2001-08-17 Composições para fins terapêuticos compreendendo excesso enantiomérico

Country Status (10)

Country Link
US (1) US6887886B2 (pt)
EP (1) EP1181932B1 (pt)
JP (1) JP2002114683A (pt)
AT (1) ATE365553T1 (pt)
BR (1) BR0103434A (pt)
CA (1) CA2355493C (pt)
DE (1) DE60129082T2 (pt)
ES (1) ES2286082T3 (pt)
GB (1) GB0020842D0 (pt)
MX (1) MXPA01008528A (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7335380B2 (en) 2000-12-29 2008-02-26 Synthon Ip Inc. Amlodipine free base
BE1014450A6 (nl) * 2000-12-29 2003-10-07 Bioorg Bv Werkwijze voor het maken van amlodipine, derivaten daarvan en voorlopers daarvoor.
AU2001294354A1 (en) * 2000-12-29 2002-07-16 Bioorganics B.V. Process for making amlodipine, derivatives thereof, and precursors therefor
AT5874U1 (de) * 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
US7153970B2 (en) 2001-07-06 2006-12-26 Lek Pharmaceuticals D.D. High purity amlodipine benzenesulfonate and a process for its preparation
GB0120808D0 (en) * 2001-08-28 2001-10-17 Pfizer Ltd Crystalline material
WO2003032954A1 (en) * 2001-10-17 2003-04-24 Dr. Reddy's Laboratories Ltd. Stabilized pharmaceutical formulations containing amlodipine maleate
CN1608051A (zh) * 2001-10-24 2005-04-20 塞普拉科有限公司 拆分氨氯地平外消旋体的方法
NL1019882C2 (nl) * 2002-02-01 2003-08-04 Synthon Licensing Amlodipine vrije base.
BE1014922A3 (nl) * 2002-03-01 2004-06-01 Pfizer Ltd Amlodipine als vrije base.
EP1348697A1 (en) * 2002-03-28 2003-10-01 Council Of Scientific & Industrial Research Process for the preparation of S(-)-amlodipine-L(+)-hemitartrate
KR100476636B1 (ko) * 2002-09-11 2005-03-17 한림제약(주) 엘-(+)-타르트레이트를 이용한 에스-(-)-암로디핀의 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1262182A3 (en) * 1991-11-26 2003-02-26 Sepracor Inc. Methods and compositions for treating hypertension, angina and other disorders using optically pure(-) amlodipine
US5389654A (en) * 1992-11-26 1995-02-14 Lek, Tovarna, Farmacevtskih In Kemicnih . . . 3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
GB9317773D0 (en) * 1993-08-26 1993-10-13 Pfizer Ltd Therapeutic compound
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine
US6333342B1 (en) * 1998-11-04 2001-12-25 Isotechnika, Inc Methods of pharmacological treatment using S(−) amlodipine

Also Published As

Publication number Publication date
CA2355493A1 (en) 2002-02-23
EP1181932B1 (en) 2007-06-27
JP2002114683A (ja) 2002-04-16
DE60129082D1 (de) 2007-08-09
US20020045648A1 (en) 2002-04-18
MXPA01008528A (es) 2005-02-17
ATE365553T1 (de) 2007-07-15
DE60129082T2 (de) 2008-02-28
EP1181932A3 (en) 2003-12-10
EP1181932A2 (en) 2002-02-27
ES2286082T3 (es) 2007-12-01
CA2355493C (en) 2005-11-29
GB0020842D0 (en) 2000-10-11
US6887886B2 (en) 2005-05-03

Similar Documents

Publication Publication Date Title
BR0103434A (pt) Composições para fins terapêuticos compreendendo excesso enantiomérico
BR0207871A (pt) Composição para liberar bisfosfonato para um alvo
EP1399414A4 (en) SUBSTITUTED TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF MALARIA
EA200000584A2 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
BR9916835A (pt) Composição de galantamina de liberação controlada
EP1734041A3 (en) Platelet ADP receptor inhibitors
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
DK1448235T3 (da) Orale, farmaceutiske sammensætninger af 5,8,14-triaza-tetracyclo[10.3.1.0(2,11).0(4.9)]-hexadeca-2(11),3,5,7,9-pentaen med kontrolleret frigivelse
IS6859A (is) Kristölluð form atorvastatíns
DE60314633D1 (de) Substituierte 1,3-diphenylprop-2-en-1-on derivate, deren herstellung und anwendungen
WO2003000200A3 (en) β-2'-OR 3'-HALONUCLEOSIDES
WO2003062191A8 (en) N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
BR0207872A (pt) Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração
GEP20063926B (en) Pharmaceutical compositions of amlodipine and atorvastatin
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
BR0211739A (pt) Novas formas polimórficas cristalinas de cloridrato de lercanidipina e processo para preparação das mesmas
WO2004064542A8 (fr) Composition pour une administration par voie orale contenant des capsaicinoïdes
MXPA03010766A (es) Nuevos compuestos y composiciones como inhibicores de las catepsinas.
ITMI20011338A0 (it) Composizioni farmaceutiche orali a rilascio immediato del principio attivo
BR0202204A (pt) Formulações estabilizadas
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
MXPA03008801A (es) Aril oxima-piperazinas utiles como antagonistas de ccr5.
DE60302951D1 (de) Pyroglutaminsäure-salz von Amlodipin
WO2004071152A3 (en) Use of s-10 hydroxy-10, 11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders
HRPK20030766B3 (en) Combination of a taxane and cyclin-dependent kinase inhibitor

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10, 13, 24 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.